本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Quoin Pharmaceuticals

8.89
-0.1202-1.33%
盘后8.890.00000.00%18:41 EDT
成交量:2,520.00
成交额:2.27万
市值:522.88万
市盈率:-0.23
高:9.01
开:9.01
低:8.89
收:9.01
数据加载中...
2023/04/07

重要事件披露

8-K - Current report
2023/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/09

重要事件披露

8-K - Current report
2023/03/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/28

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/09

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/02/08

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/03

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/08/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/04

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/04

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/04

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/08/03

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/04/22

SEC问询函

CORRESP [Cover] - Correspondence
2022/04/15

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/04/14

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]